tk88 bet

Vietnam to cooperate with French firm to conduct clinical trials of XAV-19 COVID-19 treatment drug

Deputy Minister of Health Tran Van Thuan held an online working session with France’s Xenothera company on cooperation to conduct the third phase of clinical trial of Xenothera-developed XAV-19 COVID-19 treatment drug and the transfer of XAV-19 production technology to Vietnam.
Vietnam to cooperate with French firm to conduct clinical trials of XAV-19 COVID-19 treatment drug ảnh 1Medical staff give COVID-19 treatment to patients (Photo: VNA)
Hanoi (VNA) – Deputy Minister of Health TranVan Thuan held an online working session with France’s Xenothera company oncooperation to conduct the third phase of clinical trial of Xenothera-developed XAV-19 COVID-19treatment drug and the transfer of XAV-19 production technology toVietnam.

The session drew leaders and experts of many departments ofthe Vietnamese Health Ministry, as well as Xenothera President Odile Duvaux andCEO Bernard Vanhove.

According to the Ministry of Health, XAV-19 is a COVID-19 treatment drug based on polyclonalantibodies that targets COVID-19 patients with moderate conditions.

The first and secondphases of XAV-19 clinical trials’ results showed that the drug is effectiveand safe in preventing the virus to develop, neutralizing the virus andreducing inflammation in patients.

The third phase of XAV-19 clinical trials is being conducted in some Europeancountries.

Odile Duvaux said that her company is willing to cooperatewith Vietnam in implementing the third phase of the trials, and to engage in further discussions on the transfer of the drug production technology toVietnam.

In May this year, the Ministry of Health and Solidarity ofFrance ordered 30,000 doses of XAV-19 from Xenothera.

Deputy Minister Thuan affirmed Vietnam’s readiness to cooperate with Xenotherain implementing the third phase clinical trials of XAV-19 and receivingtechnical transfer from the firm.

Following the working session, a Vietnamese firm discussed with Xenothera specific contents in preparation for the signing of a memorandum of understanding on cooperating inthe third-phase clinical trials of XAV-19 and technology transfer from the French firm./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

𒈔 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|